Abstract
Abstract Hepatocellular carcinoma (HCC) is one of the most common cancers in the United States. Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major risk factors of HCC. This review article discusses the pathogenesis behind HBV- and HCV-induced HCC, examining the ways these viruses contribute to the development of liver cancer. Furthermore, we aim to explore the therapeutic implications of viral-mediated HCC, with an interest in preventing chronic infections and subsequent HCC development. By understanding the underlying pathogenesis and therapeutic targets, we aim to contribute to improved outcomes for hepatitis-related liver cancer.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call